May 21, 2019 10:59 AM EDTUpdated 11:20 AM

Thanks to Supreme Court decision, Merck gets another chance to throw out Fosamax claims

Amber Tong

In a temporary relief for Merck amid ongoing legal drama surrounding its osteoporosis drug Fosamax, the Supreme Court has vacated the judgment of a lower …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Thanks to Supreme Court decision, Merck gets another chance to throw out Fosamax claims

Amber Tong

Sign up to read this article for free.

Director Oligonucleotide R&D

Bachem

Bubendorf, BL, Switzerland

IGM Biosciences’ autoimmune pivot lasts three months after interim data disappoint

Shoreline cuts staff as its partnership with Gilead's Kite is now in flux

Versant unveils Light Horse with $62M and a partnership with Novartis

Aiolos team reunites with $411M for new biotech with obesity drugs from China

Exclusive: First-of-its-kind infant DNA edit leads to apparent cure in disease that set back field 25 years ago

Cell therapy startup A2 Biotherapeutics nets $80M Series C

Thanks to Supreme Court de­ci­sion, Mer­ck gets an­oth­er chance to throw out Fos­amax claims

Sign up to read this article for free.

more like this

Bachem

Bubendorf, BL, Switzerland

Thanks to Supreme Court decision, Merck gets another chance to throw out Fosamax claims